Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)

Clinical trial NCT01020747 · COMPLETED

Trial details

NCT number: NCT01020747
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Respiratory Papillomatosis

Start date: 2009-11-01
Primary completion: 2011-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.